Submit or Track your Manuscript LOG-IN

HBV and HCV Seroprevalence in Hospital Admissions for Thalassemia Major in Bengbu, China

HBV and HCV Seroprevalence in Hospital Admissions for Thalassemia Major in Bengbu, China

Jun Zhang1*, Xiaocao Xu2 and Min Cao2

1Department of Blood Transfusion, The First Affiliated Hospital of Bengbu Medical College, Bengbu, 233004, China
2School of Laboratory Medical, Bengbu Medical College, Bengbu, 233030, China
* Corresponding author:


Patients with thalassemia major are exposed to a wide range of blood transition viruses that among them hepatitis B and C viruses are in high significance. This study investigates the seroprevalence of HBV and HCV in hospital admissions for thalassemia major in Bengbu, China. This study is a cross-sectional study in which information was extracted and collected from patients’ records, including gender, age, number of blood transfusions per year, HBs-Ag, HCV-Ab and Anti-HBs. The study included 630 thalassemia major patients who received regular blood transfusions at a hospital in Bengbu, China. We found that out of 630 patients of the study, there were three HBs-Ag positive, so the prevalence of HBV in this study is 0.5%. The prevalence of HCV-Ab positive was 7.1 and these individuals had a significantly older mean age than those with HCV-Ab negative. In 89.8% of patients the HBs-Ab titer was more than 10. Due to the progress of screening and selection of blood donors the prevalence of HBV infection in high-risk patients has sharply decreased in recent years. Vaccination is one of the most important protective factors in this group of the population. Therefore, administration of a reminder dose based on antibody titer is recommended in these individuals.

To share on other social networks, click on any share button. What are these?

Pakistan Journal of Zoology


Vol. 55, Iss. 1, Pages 1-500


Click here for more

Subscribe Today

Receive free updates on new articles, opportunities and benefits

Subscribe Unsubscribe